MILFORD, Mass., July 2, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) will hold its Q2 2026 financial results conference call on Tuesday, August 4, 2026, at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters' Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least September 1, 2026, at midnight Eastern Time.

About Waters Corporation

Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~16,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide. For more information, please visit www.waters.com/about.

Caspar Tudor, Head of Investor Relations
investor_relations@waters.com

View original content:https://www.prnewswire.co.uk/news-releases/waters-corporation-schedules-second-quarter-2026-earnings-conference-call-302816487.html

Tags

More Like This

Waters Corporation Schedules First Quarter 2026 Earnings Conference Call

Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call

Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026

Waters Corporation to Present at the TD Cowen Health Care Conference

Waters Corporation to Present at the Jefferies Global Healthcare Conference

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

Waters Corporation to Present at the Jefferies Global Healthcare Conference in London

Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business